Chen Schor - 29 May 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Chen Schor
Issuer symbol
KPTI
Transactions as of
29 May 2024
Net transactions value
$0
Form type
4
Filing time
30 May 2024, 17:32:35 UTC
Previous filing
26 Jan 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +69,000 $0.000000 69,000 29 May 2024 Common Stock 69,000 $0.9600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on May 29, 2025.